Physician profile
Robert M Kyler
NPI 1396746715
$762.39
in general payments reported to CMS, 2019-2025
18 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.32 · 2020: $45.29 · 2021: $69.48 · 2022: $44.22 · 2023: $259 · 2024: $171 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470 · Education: $88.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.07 |
| Education | $88.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $154.29 | 2023-2025 | Spaceoar Vue System - 10ml |
| Lilly USA, LLC | $101.36 | 2023 | Verzenio, Jaypirca, Retevmo |
| Merck Sharp & Dohme LLC | $88.35 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Novocure INC. | $54.57 | 2020-2025 | Optune Gio |
| Pfizer INC. | $53.12 | 2021-2024 | |
| Amgen INC. | $49.67 | 2020-2023 | Kyprolis |
| Novartis Pharmaceuticals Corporation | $46.59 | 2022-2024 | |
| Myovant Sciences INC. | $31.72 | 2021 | |
| Stemline Therapeutics INC. | $25.81 | 2025 | Elzonris |
| Astrazeneca Pharmaceuticals LP | $24.72 | 2023 | |
| Genzyme Corporation | $20.18 | 2024 | |
| Janssen Biotech, INC. | $20.17 | 2022 | |
| Elekta, INC. | $19.59 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.89 | 2023 | Ultomiris |
| Adc Therapeutics America, INC. | $15.32 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $15.31 | 2023 | Precisetumor |
| Varian Medical Systems, INC. | $13.04 | 2019 | |
| Olympus America INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kyler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.